Your insurance may cover Zepbound, but many plans still don’t, and almost all of them require prior authorization. Coverage depends on your plan, your BMI, your health conditions and the diagnosis your provider writes. In 2026, access improved. CVS Caremark returned Zepbound to its preferred formularies on October 1, 2026. Eligible Medicare patients can get the Zepbound KwikPen for $50 a month through the GLP-1 Bridge program. Medicare Part D can also cover Zepbound for moderate to severe sleep apnea. If your plan says no, you still have options: an appeal, the Zepbound savings card, LillyDirect self-pay from $299 a month, or a covered alternative. Here’s how to check your coverage and what to do next.
Key takeaways
- Zepbound coverage depends on your plan. Many employer plans exclude weight loss drugs entirely, and covered plans usually require prior authorization
- Common approval criteria: a BMI of 30 or higher, or 27 or higher with a weight-related condition, plus documented diet and exercise efforts
- CVS Caremark added Zepbound back as a preferred option on October 1, 2026, but each employer still decides whether to cover it
- Medicare Part D doesn’t cover weight loss drugs for weight loss alone, but it can cover Zepbound for moderate to severe obstructive sleep apnea
- Since July 2026, eligible Medicare patients can get the Zepbound KwikPen for $50 a month through the GLP-1 Bridge
- If coverage is denied, you can appeal. Many denials are overturned with better documentation
- Without coverage, LillyDirect self-pay starts at $299 a month
Why Zepbound coverage varies so much
Zepbound is the brand of tirzepatide approved for weight management. The FDA approved it for chronic weight management in 2023 and for obstructive sleep apnea (OSA) in adults with obesity in 2024. Even so, insurance companies aren’t required to cover weight loss medications.
Under the Affordable Care Act, plans must cover obesity screening and counseling, but not obesity drugs. So each plan, employer and pharmacy benefit manager (PBM) makes its own rules. That’s why two people at different companies, or even on different plans at the same company, can get different answers.
The diagnosis also matters. A plan may refuse Zepbound for weight loss but cover it for sleep apnea, since that’s a separate FDA-approved use.
How to check if your insurance covers Zepbound
Before your provider sends a prescription, take these steps:
- Check your plan’s formulary. This is the list of covered drugs. Search for “Zepbound” on your insurer’s website or app, and note the tier and any “PA” (prior authorization), “QL” (quantity limit) or “ST” (step therapy) codes
- Call the number on your insurance card. Ask whether Zepbound is covered for weight management, whether it’s covered for sleep apnea, and what the approval criteria are
- Ask about weight loss drug exclusions. Some employer plans exclude all weight loss medications, which overrides the formulary
- Ask your HR or benefits team. Employers decide whether to opt into weight loss drug coverage, and some changes only take effect at the start of a new plan year
- Check your PBM. Your pharmacy benefits may be run by CVS Caremark, Express Scripts or Optum Rx, not by your insurer directly
Questions worth asking on the call:
- Is Zepbound covered for chronic weight management? For sleep apnea?
- Is prior authorization required? What documentation do you need?
- Do I need to try another medication first?
- What will my copay be after approval?
- How often does approval need to be renewed?
Zepbound coverage by insurance type in 2026
| Insurance type | Zepbound coverage in 2026 |
|---|---|
| Employer plan | Varies. Many cover it with prior authorization, and others exclude weight loss drugs entirely |
| CVS Caremark plans | Preferred option again since October 1, 2026, alongside Wegovy, if your employer opts in |
| ACA marketplace plan | Varies by plan and state. Check the formulary before you enroll |
| Medicare Part D | Not covered for weight loss alone. Can be covered for moderate to severe sleep apnea |
| Medicare GLP-1 Bridge | Zepbound KwikPen for $50 a month if you qualify (July 2026 to December 2027) |
| Medicaid | Depends on your state. Some states have recently cut coverage of weight loss drugs |
| TRICARE and VA | Rules differ, and both usually require prior authorization |
The CVS Caremark change, explained
In July 2025, CVS Caremark removed Zepbound from its main commercial formularies and made Wegovy its preferred weight loss drug. Many patients had to switch or pay out of pocket. In May 2026, CVS Caremark reached a new agreement with Lilly. Zepbound returned as a preferred option on October 1, 2026, and Wegovy also stays preferred.
If your plan uses CVS Caremark, coverage still isn’t automatic. Your employer must adopt the updated formulary, and you’ll usually need a new prior authorization. Some employers may wait until January 2027.
Medicare and Zepbound
Medicare Part D can’t cover drugs used only for weight loss. There are two exceptions to know about:
- Sleep apnea: Part D plans can cover Zepbound for adults with obesity and moderate to severe OSA, usually with prior authorization and a sleep study
- The GLP-1 Bridge program: Since July 1, 2026, Medicare patients with Part D coverage can get the Zepbound KwikPen for a $50 monthly copay if they qualify. The pilot runs through December 31, 2027
To qualify for the Bridge, you’ll generally need one of the following:
- A BMI of 35 or higher
- A BMI of 30 or higher with stage 3a or higher kidney disease, certain types of heart failure or uncontrolled high blood pressure
- A BMI of 27 or higher with prediabetes, a previous heart attack or stroke, or blocked arteries in the legs or arms
Your provider submits the request. People already covered for a GLP-1 under Part D, for example for type 2 diabetes or sleep apnea, aren’t eligible for the Bridge.
Weight loss care at Heally: tirzepatide program · weight loss lab panel · meet our doctors
How to get insurance to cover Zepbound
Step 1: Get a prior authorization
Prior authorization (PA) is a request from your provider explaining why you need Zepbound. Most plans that cover it require one. A strong request usually includes:
- Your BMI and weight history, with measured weights over time
- Weight-related conditions, such as high blood pressure, prediabetes, high cholesterol, sleep apnea, fatty liver disease or joint problems
- Past weight loss efforts, including diet programs, exercise or nutrition counseling, often for at least 3 to 6 months
- Previous medications you’ve tried, if your plan requires step therapy
- Lab results, such as HbA1c, cholesterol and liver tests
- A sleep study, if you’re seeking coverage for sleep apnea
Many plans approve Zepbound for 6 months at first. To renew, you’ll often need to show you’ve lost a certain amount of weight, commonly at least 5%, and are still taking it.
Step 2: Try step therapy, if your plan requires it
Some plans require you to try a cheaper drug first, such as Wegovy or an older weight loss medication. If you’ve already tried it, or have a medical reason not to, your provider can request an exception.
Step 3: Appeal a denial
A denial isn’t always the final answer. To appeal:
- Read the denial letter to find the exact reason, such as missing documentation, BMI criteria or a plan exclusion
- Ask your provider to submit an appeal with a letter of medical necessity and the missing records
- Request a peer-to-peer review, where your provider speaks directly with the plan’s doctor
- File within the deadline. Most plans allow up to 180 days to file an internal appeal
- Ask for an external review if your internal appeal fails. ACA-compliant plans must offer an independent review
Appeals work best when the denial was about documentation. If your plan excludes weight loss drugs entirely, an appeal usually won’t change that, but a sleep apnea diagnosis or an employer exception might.
What to do if Zepbound isn’t covered
Use the Zepbound savings card
Lilly’s savings card has two versions:
| Your situation | What you may pay |
|---|---|
| Commercial insurance that covers Zepbound | As little as $25 a month for the single-dose pen (savings up to $100 a month, $1,300 a year) |
| Commercial insurance that doesn’t cover Zepbound | As little as $499 a month for the single-dose pen, or $299 to $449 for the KwikPen, depending on dose |
The savings card can’t be used with Medicare, Medicaid, TRICARE or VA coverage. The current terms run through December 31, 2026. For step-by-step activation, see how to use the Zepbound savings card.
Pay through LillyDirect
LillyDirect sells Zepbound vials and KwikPens at self-pay prices, whatever your insurance status:
| Dose | LillyDirect self-pay price per month |
|---|---|
| 2.5 mg | $299 |
| 5 mg | $399 |
| 7.5 mg to 15 mg | $449, if you refill within 45 days of your last delivery |
If you refill late, the price for higher doses goes up. That makes staying on schedule worth it, both for your results and your budget. Medicare patients can also use LillyDirect self-pay.
Ask about a covered alternative
If your plan won’t cover Zepbound, it may cover another option:
- Wegovy (semaglutide), which is preferred on many formularies, including CVS Caremark. See what to do if Wegovy isn’t covered if you hit the same problem there
- The Wegovy pill, with self-pay prices starting at $149 a month
- Foundayo (orforglipron), Lilly’s daily GLP-1 pill, which CVS Caremark added in June 2026
- Mounjaro, if you have type 2 diabetes. It’s the same drug as Zepbound but approved for diabetes, so diabetes coverage rules apply. Plans won’t cover it for weight loss alone
For a comparison of the two main options, see tirzepatide vs semaglutide: dosage and results. If you’re changing medications, read how to switch from Zepbound to Wegovy.
Use HSA or FSA funds
Prescription weight loss medications are often eligible for health savings account (HSA) or flexible spending account (FSA) funds when used to treat obesity. Paying with pre-tax dollars lowers your real cost. Check your plan’s rules.
Avoid unapproved compounded tirzepatide
The FDA removed tirzepatide from its shortage list in December 2024, and the grace period for compounding pharmacies ended in March 2025. Compounded tirzepatide is not FDA approved, and the FDA has received reports of dosing errors and hospitalizations linked to compounded GLP-1s. With LillyDirect prices starting at $299, the savings from unapproved versions are much smaller than they used to be.
Can I switch to an insurance plan that covers Zepbound?
Possibly, but plan carefully:
- During open enrollment, check each plan’s formulary for Zepbound and its prior authorization rules before you choose
- Look at the whole cost, including premiums, deductibles and your copay after approval. A plan that covers Zepbound may cost more overall
- Remember that formularies change each year, and sometimes mid-year
- Medicare patients can review Part D plans during open enrollment, from October 15 to December 7 each year
How much does Zepbound cost without insurance?
At list price, Zepbound costs about $1,060 to $1,090 for a month’s supply of single-dose pens. Few people need to pay that in 2026. With LillyDirect, you pay $299 to $449 a month, depending on your dose. Heally’s tirzepatide program starts at $299 a month. For a look at the semaglutide side of the market, see the cost of semaglutide and where to find discounts.
The bottom line
Insurance coverage for Zepbound is improving but still varies widely. Check your formulary, call your plan and ask about prior authorization, step therapy and weight loss drug exclusions. A strong prior authorization with your BMI, conditions and weight loss history gives you the best chance of approval. If you’re denied, appeal with better documentation. If your plan doesn’t cover Zepbound at all, the savings card, LillyDirect self-pay from $299 a month, the Medicare GLP-1 Bridge or a covered alternative can still make treatment affordable.
Not sure what your plan covers? A Heally provider can help with your weight loss prescription, including documentation for prior authorization and self-pay options. See how Heally works.
FAQ
Does insurance cover Zepbound for weight loss?
Sometimes. Coverage depends on your plan. Many employer plans cover Zepbound with prior authorization, while others exclude weight loss drugs entirely. Check your formulary and call your insurer to confirm.
Why was my Zepbound prescription denied?
Common reasons include missing documentation, not meeting BMI criteria, step therapy requirements or a plan exclusion for weight loss drugs. Your denial letter will list the reason, and your provider can often address it in an appeal.
Does CVS Caremark cover Zepbound in 2026?
Yes, for many plans. CVS Caremark returned Zepbound to its preferred formularies on October 1, 2026, alongside Wegovy. Your employer must still opt in, and prior authorization is usually required.
Does Medicare cover Zepbound?
Not for weight loss alone. Part D plans can cover Zepbound for moderate to severe obstructive sleep apnea. Since July 2026, eligible Medicare patients can also get the Zepbound KwikPen for $50 a month through the GLP-1 Bridge program.
How much is Zepbound with the savings card?
With commercial insurance that covers Zepbound, you may pay as little as $25 a month. If your commercial plan doesn’t cover it, you may pay as little as $499 a month for single-dose pens, or $299 to $449 for the KwikPen.
What’s the cheapest way to get Zepbound without insurance?
LillyDirect self-pay, starting at $299 a month for the 2.5 mg dose and up to $449 a month for higher doses if you refill on time.
Can I get Mounjaro covered instead of Zepbound?
Only if you have type 2 diabetes. Mounjaro contains the same drug as Zepbound, but it’s approved for diabetes, so plans cover it for diabetes rather than weight loss.
Sources
- Healthcare Dive. “CVS obesity drug deal puts Lilly on equal footing with Novo,” May 2026. healthcaredive.com
- AARP. “Medicare $50 GLP-1 Bridge access and eligibility,” 2026. aarp.org
- Healthline. “Is Zepbound covered by Medicare?” 2025. healthline.com
- Eli Lilly and Company. “Zepbound pricing with or without insurance.” pricinginfo.lilly.com
- The Rx Index. “Zepbound savings card: $25, $499, or $299?” October 2026. therxindex.com
- Healthinsurance.org. “Does health insurance cover drugs used for weight loss?” healthinsurance.org
- American Medical Association. “What is prior authorization?” ama-assn.org
- US Food and Drug Administration. “FDA’s concerns with unapproved GLP-1 drugs used for weight loss.” fda.gov
This article is for educational purposes only and is not a substitute for professional medical or insurance advice. Coverage rules, prices and savings programs change often, so confirm details with your insurer, pharmacy or Lilly. Zepbound is available by prescription only and carries an FDA boxed warning about the risk of thyroid C-cell tumors. Do not use it if you or a family member has had medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
